DrugDashboards

Market view

clindamycin phosphate and tretinoin · Gel

8 marketed package NDCs · 4 active manufacturers

Most dispensed: 12 mg/g; .25 mg/g · Gel · #1 tube/carton / 30 g in 1 tube · 12 mg/g; .25 mg/g · Gel · #1 tube/carton / 60 g in 1 tube · 10 mg/g; .25 mg/g · Gel · #1 tube/carton / 30 g in 1 tube · 10 mg/g; .25 mg/g · Gel · #1 tube/carton / 60 g in 1 tube

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 28% over the past year, to $3.86 per gram. The brand runs $11.41 per gram 3× more.

Price range and competition

RSS: changes for this drug
priced separately — they are not the same market

Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$5.00$10.00$15.00Sep 2016Sep 202604companies actively selling

Latest · Sep 2026 — typical price $3.86 · middle half $3.40$4.33 · full range $3.40$4.33 · 4 products · 4 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per gramSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for clindamycin phosphate and tretinoin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Retinoid, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Clindamycin phosphate and tretinoin in shortage right now?
No. FDA does not currently list Clindamycin phosphate and tretinoin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Clindamycin phosphate and tretinoin?
4 companies have marketed Clindamycin phosphate and tretinoin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Clindamycin phosphate and tretinoin cost?
The typical pharmacy pays about $3.86 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.